Covariate | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P value | HR | 95% CI | P value | |
Sex | ||||||
Female | 1 | 1 | ||||
Male | 0.632 | 0.432–0.923 | 0.018a | 1.977 | 1.191–3.282 | 0.001 |
Age (years) | 1.034 | 1.011–1.059 | 0.004a | 1.062 | 1.030 –1.094 | < 0.001 |
ASA | ||||||
I–II | 1 | |||||
III–IV | 1.374 | 0.923–2.044 | 0.117 | |||
ECOG grade | ||||||
0–1 | 1 | |||||
2–4 | 1.634 | 0.971–2.748 | 0.064a | |||
Haemoglobin | 0.961 | 0.805–1.148 | 0.661 | |||
Bilirubin | 1.000 | 0.999–1.001 | 0.833b | |||
CRP | 1.011 | 1.002–1.020 | 0.022 | |||
Albumin | 0.952 | 0.920–0.986 | 0.006 | |||
CAR | 1.406 | 1.038–1.905 | 0.028a | 1.745 | 1.200–2.539 | 0.004 |
mGPS | ||||||
0 | 1 | |||||
1 | 1.419 | 0.946–2.128 | 0.090 | |||
2 | 1.953 | 0.971–3.929 | 0.061 | |||
CEA | 1.011 | 0.999–1.022 | 0.074 | |||
CA 19.9 | 1.215 | 0.940–1.570 | 0.138 | |||
Supplementary nutrition | ||||||
No | 1 | |||||
Enteral | 1.264 | 0.838–1.905 | 0.264 | |||
Parenteral | 1.612 | 0.588–3.789 | 0.272 | |||
Neoadjuvant therapy | ||||||
No | 1 | |||||
Yes | 0.541 | 0.171–1.710 | 0.296b | |||
Approach | ||||||
Open or conversion | 1 | |||||
Laparoscopy | 0.937 | 0.380–2.306 | 0.887 | |||
Type resection | ||||||
Pancreas head | 1 | |||||
Pancreas other | 1.187 | 0.756–1.865 | 0.456 b | |||
Complication | ||||||
Clavien–Dindo 0-2 | 1 | |||||
Clavien–Dindo 3-5 | 1.266 | 0.778–2.059 | 0.342 | |||
Tumour size | 1.007 | 0.996–1.018 | 0.237 b | |||
Differentiation grade | ||||||
Well or moderate | 1 | 1 | ||||
Poorly | 1.271 | 0.837–1.931 | 0.261b | 2.812 | 1.627–4.861 | < 0.001 |
Metastatic lymph node ratio | 2.946 | 1.154–7.521 | 0.024a | |||
Para-aortic lymph node | ||||||
No metastasis | 1 | |||||
One or more metastases | 3.299 | 1.738–6.262 | < 0.001a | 4.489 | 1.883–10.702 | < 0.001 |
Radicality | ||||||
R0 | 1 | |||||
R1–R2 | 1.386 | 0.952–2.018 | 0.089a |